Bischloroanthrabenzoxocinone ((-)BABX) is a selective inhibitor of Type II fatty acid synthesis (FASII). BABX showed IC50 values of 11.4 and 35.3 µg/ml in the S. aureus and E. coli FASII assays, respectively, with comparable antibacterial activities. FASII is essential to bacterial cell viability and is a promising target for the development of novel antibiotics.
Bischloroanthrabenzoxocinone is soluble in ethanol, methanol, DMF and DMSO.
CAS Number
866022-28-8
Molecular Formula
C28H24O7Cl2
Molecular Weight
542.1
Mechanism of Action
BABX has been shown to inhibit agonist binding to Liver X receptors (LXR). These receptors regulate the expression of the ABCA1 gene, which mediates the efflux of cholesterol from cells.
Storage Conditions
-20°C